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Abstract 
 
Leaving the European Union (so-called ‘Brexit’) is a ‘critical moment’ for health policy reform 
which can pave the way to different pathways, including, a ‘critical juncture’. Given that 
Brexit cannot be undone without a second referendum, it opens up opportunities to elude 
European constraints for reform along the lines of equity, employment rights and patient 
choice. Brexit deepens the financial crisis of the National Health Service (NHS) by increasing 
hiring costs and imposing new transaction costs to accommodate patient cross-border 
mobility and international public health needs. Given the weak sustainability of the NHS, it 
could open an opportunity for major system reform. 
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Introduction 
 
Health care and the National Health Service (NHS) budget were intrinsically 
associated with the Brexit referendum narrative. During the referendum, the slogan used by 
the ‘leave campaign’ to garner support for their cause weighed heavily on the significant 
savings Brexit would bring from not contributing to the EU budget, which could rather be 
invested in the NHS (and estimated to amount to the much mentioned ‘£350 million a week 
savings’). However, by the time the outcome of the referendum was announced, most of 
those promises had already faded away, and it became evident that health care austerity 
had very little to do with the European Union. This paper examines the most immediate 
implications of Brexit for healthcare, and how exit from both the European Union and the 
Single Market will affect the future of the NHS.  
In examining the consequences of Brexit, one ought to factor in the weak financial 
sustainability of the NHS. According to estimates from the King’s Fund, in 2015–16 the NHS 
had the largest deficit in its history. NHS funding has been unable to keep pace with a 
growing demand for services, especially given the near absence of expenditure increases 
(0.1 per cent in 2019). This is concerning given that quality shortcomings can be associated 
with limited staff availability.  Evidence of resource-driven failures of care, such as the case 
of the Mid-Staffordshire NHS Foundation Trust, was reported in the Francis report (Dunna et 
al., 2016) as a paradigmatic example of  how resource constraints can put health  services 
under strain. For instance, the availability of community nurses in England has sharply 
declined in the last decade in about 19 per cent over the last decade in England (Addicott et 
al., 2015), despite the expanded workloads. 
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The common reaction to such staff shortages has traditionally been a higher reliance 
on private temporary contract agencies to fill workforce gaps and, more generally, on 
private providers who already make up 18 per cent of NHS spend on community health 
services (Lafond et al., 2014). Given the time needed to train new nurses, these pressures 
create an average nursing vacancy rate of 15–20 per cent in community health services 
(Foot et al, 2014).  In that scenario, the most obvious choice is to hire internationally, and 
especially from EU countries. However, leaving the European Union in such a context 
creates a conundrum for English hospitals regarding how to square their objectives on 
‘quality’ and ‘cost’: any extra quality inevitably entails extra resources which are not 
available without extra funding. Hence, Brexit raises questions about the financial 
sustainability of an unreformed NHS, that is an NHS without extra funding.  
In what follows, we examine the expected effects of Brexit on the NHS, in a generic 
way, without detailed information on the exact terms of the final deal. At the time of writing 
the article, all estimates would require making a number of unreasonable assumptions 
about the effect of leaving the European Union, hence we mainly focus on the potential 
institutional consequences instead. This paper will concentrate on identifying some of the 
main issues that Brexit brings to the organisation of the NHS, and specifically on its effects 
on worker and patient mobility. I will argue that Brexit entails an unparalleled institutional 
and economic shock that gives rise to a ‘critical moment ‘for policy reform given the weak 
financial position (fiscal deficit) of the NHS. Specifically, leaving the EU will entail a rise in 
hiring costs and will impose new transaction costs to accommodate both patient cross-
border mobility and international public health needs. 
 I further argue that the outcome of such a critical moment includes several possible 
trajectories, which may involve a progressive process of substitution of EU for non-EU staff, 
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and adjustments to the potential reductions in NHS funding. In some extreme 
circumstances, it may give rise to a ‘critical junction’ (Capoccia and Kelemen, 2007; Greer, 
2009).  
 
 Nonetheless, for a critical juncture to take place, Brexit would have to shift the 
preferences of sectors of the electorate (middle class) and political agents towards a 
widespread system reform and further privatisation in the financing of health care services 
(e.g. private health insurance uptake). This includes a heavier reliance on private agency 
providers to counteract the shortages in the NHS  health care staff. However, the extent to 
which the fiscal consolidation of the NHS takes policy priority (over injecting funds to 
maintaining quality standards) at this ‘critical moment’ is crucial for a critical juncture to 
unfold. Brexit is estimated to lead to a reduction of 6.3–9.5 per cent of national income (Van 
Reenen, 2017) 1
, and one can expect expenditure cuts if fiscal sustainability goals are maintained. 
Alternatively, if further health care investment is prioritised after Brexit, it is unlikely that a 
critical juncture will take place, and instead a more moderate transformation in the 
functioning of the NHS should be expected.  
The rest of the paper will be devoted to substantiating these arguments. The 
structure of the paper is as follows. Next, we will discuss the costs of Brexit on the NHS, 
followed by the effect of EU governance on the health system. We will then look at the 
effect Brexit has on the mobility of health and social care workers, and also of patients. The 
paper will then examine, in a separate section, other effects that Brexit may produce in 
addition to those associated with mobility such as effects in the medicines market. The 
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paper will conclude with a discussion section that provides some of the lessons and policy 
implications of Brexit for the NHS.  
 
Brexit and its costs to the NHS 
 
After Brexit, the UK might save a contribution to the EU funds, but estimates indicate 
at most saving of 0.31 per cent of national income (0.53 per cent of fiscal transfer minus 
0.22 per cent, namely the contribution of the EU to business, universities and other bodies). 
However, even such a benefit will dissipate if Britain, as it is expected, is required to pay a 
contribution to access some aspects of the single market (van Reenen, 2017). The latter 
includes speedy access to key health technologies and, most importantly, cross-border care 
that both EU nationals in the UK and UK nationals in the EU receive2.  
The effects of Brexit on the NHS will be more critical in the management of human 
resources. Specifically, retention and hiring of EU health professionals will be more 
challenging both on pay and on social integration of European staff 3.
Leaving the EU entails the introduction of important restrictions on labour mobility 
which can shift labour costs upwards (e.g., higher medical fees will be required to 
incentivise a declining medical work force and vacancies might need to increasingly be 
covered by temporary staff). In addition, one can expect higher transaction costs to 
purchase intermediary goods (e.g. medicines and medical devices when we lose access to 
the single market), which in turn, may force the NHS to adopt tighter budgets on both 
medical research and health services. Part of the latter suggeststhe short-term higher costs 
of new technologies due to changes in the exchange rate vis a vis the Euro. However, part of 
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the increase in transaction costs will result from potential new tariffs, and especially, non-
tariff barriers, once single market regulations become non-binding tot he UK.  
On the patient’s side, the UK may lose out significantly after Brexit as the balance of 
payments associated with free patient mobility seems to have traditionally benefited the UK 
given that British expats tend, overall, to be older than EU residents in the UK which are on 
average younger, healthier and more highly skilled. Specific attention will have to be 
focused on the large share of British pensioners in some EU countries such as Spain and 
France (McKee and Glasworthy, 2016). Hence, any change in those terms would be 
expected to add additional pressures to the already weak financial position of the NHS.  
 
 
European Influence and Health System Governance 
 
In evaluating the effects of Brexit on health care governance, it is important to keep 
in mind that a pre-Brexit Cabinet Office document defined the balance of competence on 
health policy between the EU and the UK as ‘broadly appropriate’ (Cabinet Office, 2013). 
Hence, Brexit entails departing from such a ‘balanced scenario’.  
From a governance perspective, the European Union plays a modest role in health 
policy (as it primarily acts as a ‘regulatory state’). Article 168(7) of  the Treaty of the EU 
assigns to member states the responsibility for health policy, management of health 
services and the allocation of medical resources. However, progressively, the EU has 
become a more important actor in a number of health care areas including cross-border 
healthcare, tobacco and alcohol, AIDs and cancer, health information, organs and blood 
donation as well as intermediate goods subject to internal market regulation. The latter 
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(e.g., medicines, medical devices) are scrutinised by the European Court of Justice (ECJ) 
alongside the regulation of health professionals. All these areas are hence directly affected 
by Brexit. However, indirectly, a number of other areas are also impacted. Single market 
legislation has directly affected both public procurement and provided unified new 
medicine licenses and labour market regulations such as the Working Time Directive (WTD). 
Treaty articles have legislated on mutual recognition of training and have been active in 
limiting the capacity of governments to discriminate in favour of domestic suppliers and 
keep the labour market open to competition.  However, the direct EU effects on governance 
have been more limited and mainly operate through ‘soft governance’, namely the so-called 
‘open methods of coordination’ (OMC)4 
and recently European Semester policies5 
.  
Health care reform over the last decades has focused primarily on developing 
internal provider choice and competition policies much in line with European single market 
principles. However, fiscal consolidation has been a pressing matter for a long time. Already, 
the Tony Blair’s governments addressed the chronic problem of underfunding by injecting 
funds into the system and committed to raise spending to the EU average. Europe was used 
as a benchmark to raise health care investment.  Furthermore, the European Commission 
has played a fairly active role both by coordinating the exchange of good practices (e.g. 
using health care targets referring to  the attintment of healthy life-years alongside the 
provision of long-term care), and by adopting some fiscal surveillance mechanisms in the 
content of the European Semester (Azzopardi-Muscat et al., 2015). Finally, leaving the EU 
may potentially loosen the influences that have made it possible for the UK to implement 
desirable policies by overcoming lobbies and other obstacles.6
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Other sources prompting the Europeanisation of health policy include the adoption 
of the European Charter of Fundamental Rights that recognises the right to both curative 
and preventive care (art 35), and the 2006 European Council statement of overarching 
values of universality, access to good-quality care, equity and solidarity. The Lisbon Treaty in 
2007 strengthened the EU role on health, and the EC Health Strategy 2008–2013 (European 
Commission, 2007) states a commitment to reducing inequities in health, promoting ‘health 
literacy’ and especially, including ‘health’ as a policy objective in other policies such as 
poverty reduction. Consistently, the health programme 2014–2020 reiterates the values of 
equity and solidarity and the goal of reducing health inequalities. However, although often 
constraining, such actions and statements have not been visible enough and the 
programme's impact' on policies and outcomes is indirect and hard to establish.  
 
Health and social care workers mobility 
Staff  recruitment 
 The UK has a long history of being a recruiter of internationally educated health 
professionals that have helped sustain the NHS (Aiken, 2004). Since the implementation of 
Regulation 1408/71 in 1971, establishing the portability of social security rights for 
employees moving across borders, the European Commission has promoted the setting up 
of a so-called ‘European health professionals space’.  As stated by the Royal College of 
Nursing (2017), common standards on training and recognition of qualifications have 
facilitated European recruitment. Conversely, changes to those regulations are likely to give 
rise to new legal and administration costs which will make such recruitment most costly.  
 Although the UK has been an EU member since 1973, the inflow of EU health 
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professionals to the UK significantly expanded after 2004. This was due to the accession of 
eastern European countries and, especially, to the implementation of some key regulations 
(e.g. education and training standardisation to enable automatic registration in another EU 
country, and EU Directive 2005/36/EC which  allows temporary work entitlements to health 
professionals). Given that both coincided with a significant reduction in the numbers of 
trainees, this inflow helped to cope with the local undersupply of health professionals. 
Indeed, the considerably lower wages in the countries of origin of EU migrants accessing the 
UK after 2004, led to NHS recruitment agencies attracting a significant number of 
professionals (Ballard, 2004; Blitz, 2005), saving the UK taxpayer the training of such staff.  
 However, even with such an inflow of EU professionals, the NHS has struggled to recruit 
and retain permanent staff. In 2014, there was a shortfall of 5.9 per cent, and in social care 
5.4 per cent, rising to 7.7 per cent in domiciliary care services (King’s Fund, 2016), and about 
one-third of all UK nurses are due to retire in the next ten years (Royal College of Nursing, 
2017). The problem is more alarming when one looks at the GP workforce (Buchan et al, 
2016). A recent report of the Royal College of Physicians (2017) suggests that, in 2016, 86 
per cent of physicians experienced shortages across clinical teams. According to the English 
Health Service’s Electronic Staff Record (2016), there were around 144,000 EU nationals 
working in health and social care organisations across England in 2016 of which 57,063 
worked in health care in the NHS; and 6,209 worked in independent health organisations 
providing infrastructure support. The EU nationals’ workforce is made up of 38,883 clinical 
staff; 10,136 doctors; 20,711 nurses; 11,732 clinical support staff and 1,336 midwives. 
Overall, EU immigrants make up about 5 per cent of English NHS staff and about 5 per cent 
of the English population, according to the best available data. Across the UK, EU 
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immigrants make up 9 per cent of registered doctors and 4 per cent of registered nurses.  
However, such percentage are much higher when one looks at specialised consultants.  
The research so far has been able to identify some different patterns of EU staff by country 
of origin. Baker (2016) distinguishes EU staff by nationality and finds that a third of the staff 
from ‘old’ EU countries are Irish and 72 per cent of EU staff in the NHS are women. 
Importantly, when the data disaggregates between old (pre-2004 members) and new 
member states (‘A8’ East European countries), one finds an increase from 2.2 per cent to 3.8 
per cent between 2009 and 2016 for the former, and a smaller increase from 0.7 per cent to 
1.5 per cent for the latter7. 
Of the staff that recently joined in 2015–16 , 13  per cent were from other EU countries 
while, for nurses, the figure was 18 per cent. This suggests that accession did not affect the 
NHS as it did other sectors of the economy, but that EU staff make up an increasing share of 
new hires. In particular, the inflow of nurses has increased in recent years, notably from 
European Union (EU) countries, in response to recruitment difficulties.  
 
Another important driver of staff expansion is local policy dynamics and, specifically, 
concerns over quality in English hospitals after the publication of the Francis Report (2013) 
which identified a link between shortages and poor quality of care. The latter leads to an 
increase in the demand for nurses. However, back in 2015, 93 per cent of NHS trusts in 
England reported registered nurse shortages (NHS Employers, 2015) and estimates point 
out that recent staff increases in 2015/16 and 2016/17 are unlikely to alleviate the 
immediate and short-term needs and the NHS will be required to rely on nurses trained in 
the EU or overseas.  
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Counterfactuals   
To understand the impact of Brexit one can look for potential counterfactuals. One 
example can be found in the 2010 restrictions on hiring non-EU immigrants which had a 
significant influence on NHS recruitment, mostly bringing about transaction costs (e.g. legal 
restrictions) on the hiring of health professionals8.
For instance, Baker (2016) finds a reduction of 37 per cent in the number of Indian 
doctors working in the UK from 2009 to 2016 due to such restrictions. However, to such 
legal restrictions one could add wider ‘social restraints’, namely individuals being 
discouraged to come to Britain due to a change in the working environment after Brexit 
(e.g., migrants ‚othering’ and more generally being the scapegoat of staff and resource 
shortages) . The latter would lead the NHS to run through difficulties in retaining staff.  In 
addition, one can point to cultural constraints and experiences of discrimination as well as 
communication constraints which may discourage staff from staying in the UK (Young et al., 
2010). These types of restrictions are likely to exert an independent effect even when legal 
restrictions are lifted. The consequences of such restriction are more concerning when they 
affect highly skilled professionals as often they cannot be easily substituted by nationals (it 
takes seven years to train new doctors and there is no guarantee that they will stay in the 
country. In contrast, hiring EU doctors comes at no major training cost, and guarantees 
comparable quality of care).  So far, early figures from the Royal College of Nursing (2017) 
indicate that 2,700 EU nurses left the health service in 2016, compared to 1,600 in 2014 an 
overall representing a 68 per cent increase. 
An important reduction in the UK’sattractiveness to employees lies in the reduced 
role of research as part of the job description for doctors which, unless Britain participates 
in EU programmes, will rely on national funding only. Furthermore, limits to the free 
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movement of researchers across Europe are likely to affect the collaboration of  UK 
researchers with European counterparts (Ghosh, 2016). To grasp an idea of the effects, one 
could look to Switzerland where , the reduction of immigration from the EU led to a 40 per 
cent reduction in research funding (McKee and Galsworthy, 2016). 
Effects on wages 
One of the potential effects of Brexit will be on wages. Although empirical studies 
find that the areas of the UK with large increases in EU immigration did not give rise to a job 
and pay decline of UK-born workers (Wadsworth et al., 2015),  Dustmann et al. (2013) found 
that immigration led to wage losses for those in the bottom 10 per cent of the pay 
distribution and larger wage gains for those in the middle. More precisely, estimates imply 
that the wave of EU immigration between 2004 and 2015 reduced wages in the bottom 
decile by 1 per cent, and overall increased wages for the median workers by 1.2 per cent . 
Hence, the expansion of EU immigration led to lower wages marginally at the bottom decile 
alone, but not at the top. However, reducing EU immigration would then increase wages on 
both ends of the wage distribution. In such a scenario, the options available include 
incentivizing EU immigration or, expanding the health and social care spending in an 
attempt to transform it into a higher-wage sector, while aiming at increasing its productivity 
(Sumption, 2017).  Hence, the trade-off  is between saving on NHS funding by hiring health 
professionals from overseas, or expanding health investment further to incentivise local 
recruits (with some delay).   
 
Working Times Directive 
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Brexit may provide an opportunity to overcome the contentious application of the European 
Working Time Directive (WTD) which limits the maximum amount of time that employees in 
any sector can work to 48 hours each week (alongside rest periods and annual leave). 
Although abandoning the WTD might increase the flexibility in the labour market for health 
professionals, it will entail the imposition of tougher working conditions (Sheldon, 2004; 
Greer, 2006). The WTD was put in place to harmonise labour standards across the EU and 
minimise the risk of ‘social dumping’. Hence, lifting working time limits is likely to cause a 
deterioration in the quality of NHS employment and make working for the NHS less 
attractive. Specifically, the Royal College of Nursing (2017) has drawn attention to the 
importance of keeping the WTD to ‘reduce fatigue’ which can stand out as a risk to patients. 
In other words, Brexit opens the door to hardening the working conditions of NHS 
employees, at the ‘critical moment’ of fiscal consolidation.  
 
Effects on patient mobility 
 
Alongside its effects on the functioning of the labour market, Brexit  has important 
implications for cross-border health care, which has historically enabled health care 
providers to send patients abroad for treatment provided prior authorisation had been 
granted9. Indeed, the Kohll and Decker procedure grants patients freedom to choose a 
provider abroad without prior authorisation from their home country, too, and with the 
added entitlement to reimbursement from their national health care system (under their 
home arrangements and costs). Hence, patient mobility gives rise to an incentive to seek for 
higher quality and/or cheaper treatments abroad, and subsequently apply for 
reimbursement without affecting significantly the utilisation and quality of care at both 
14 
 
ends1. The overall impact of patient mobility on the NHS has, so far, been limited in 
magnitude. However, its reduction encompasses important restrictions in the use of health 
care which may have detrimental welfare consequences.  
 
 Rosenmőller et al. (2006) dinstinguish a number of scenarios where patients can benefit 
from patient mobility, which we reduce here to three. First, one might consider care to 
British citizens retiring to an EU country and hence wishing to use health care in the country 
of retirement. The UK in 2013 paid £805 million to EEA countries, the majority of which was 
for UK state pensioners living in other EEA countries (Cabinet Office, 2013). Hence, leaving 
the EU entails additional transaction costs to set up a number of specific reciprocal cross-
country agreements to guarantee access to health care for British retirees10.
                                                     
1
 Wadsworth (2013) finds no greater usage of doctors and hospitals by non-UK born in the UK and 
Giuntella et al. (2015) find barely no effect on NHS waiting times. 
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Second, some patients might take advantage of EU legislation to overcome capacity 
restrictions in the NHS. A survey conducted in 2007 found that many more people may be 
willing to travel for care within the EU than currently do so: over half (53 per cent) of all EU 
respondents to the European Commission survey, including 54 per cent of UK respondents, 
said they would be willing to travel to another EU country to seek medical treatment (The 
Gallup Organization, 2008). Hence, in this instance cross-border mobility is a potential  
mechanism to reduce bottlenecks in the NHS which would not be available after Brexit. 
Finally, cross-border care can emerge when patients try to take advantage of treatments 
that are not available in the UK (e.g., a special medical treatment requiring high technology 
equipment), or that have been delisted for reimbursement in Britain. For instance, cancer 
patients who, having asked to pay privately for expensive anti-cancer drugs do not manage 
to secure funding (Dawson and Mountford, 2008).  
After Brexit, UK citizens face a more restricted set of choices over health care treatments. 
The only advantage, from a welfare perspective, of restricting mobility is that, discouraging 
mobility reduces competition between health systems, and hence it could be argued that it 
deters a  a ‘race to the bottom’ in health care investment to take place. However, given that 
patients are rarely asked to pay for health care in most European countires, and mobility is 
rarely the result of waiting lists (a ruling by the European Court of Justice in 2006 found that 
compliance with a national waiting time target is not in itself sufficient to demonstrate that 
a patient is not experiencing undue delay in receiving care) such a race to the bottom does 
not seem to be taking place. I fit does, it driven by a search for better quality of care ratehr 
than lower costs.  In contrast, restricting patient mobility after Brexit  entails setting up 
additional controls at the point of access to health care  which, inevitably, encompass a 
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change in the traditional conception of ‘free care at the point of use’. 
 
Finally, unless ist is negociated otherwise, British tourists might be excluded from the 
European Health Insurance Card (EHIC) programme, which provides free emergency care. So 
far, the average use of health services by immigrants and visitors appears to be lower than 
that of people born in the United Kingdom, which may be partly due to the fact that 
immigrants and visitors are, on average, younger (Steventon and Bardsley, 2011). Overall, 
Department of Health data show that it cost £30m in 2013–14 to meet the costs of 
European visitors using the NHS. This is less than one-fifth of the £155m cost to other states 
in the European single market for treating ill British tourists. Hence, the UK would 
experience a net loss from losing the existing reciprocal access to health care. The UK 
introduction of  a £200-a-year health ‘surcharge’ for all new migrants from outside the EEA 
(£150 a year for overseas students) who stay in the UK for longer than six months has been 
proposed, and such a surchargeis payable upfront and covers migrants for the duration of 
their visa.  
 
Finally, leaving the EU entails foregoing the efficiency gains from running global public 
services at a larger European scale unless the UK decides to join those specific programmes 
such as the European Centre for Disease Control (ECDC). Again, the effect results in higher 
costs to the British tax payer.  
 
 
Conclusion 
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From a historical standpoint, major health systems reforms in the UK have 
traditionally been attributed to ‘accidents of history’ in critical moments (Tuohy, 1999). This 
paper has argued that Brexit is a ‘critical moment’ for the NHS. Specifically, we argue that, in 
all certainty, it will entail a cost increase associated with a rise in the costs of intermediary 
inputs, especially labour costs, to attract qualified staff alongside other inputs affected by 
non-tariff barriers (e.g. rules of origin checks, regulatory barriers, border controls etc.) . This 
takes place in the midst of a process of fiscal consolidation (leading to longer waiting list, 
waiting times etc) which creates additional financial pressures for more substantial and 
transformative policy reform.  However, whether it gives rise to a ‘critical juncture’ will 
largely depend on the exact Brexit deal, the contradictions in the health policy debate and, 
specifically, how the UK solves the quality–cost conundrum. If publicly funded provision of 
health care is costlier to the British public, and there is no appetite for further tax increases, 
Brexit might entail spending cuts. If NHS quality deteriorates, some share of the population 
might well take up private health insurance and reduce their support for further NHS 
improvements in quality (Costa-Font and Jofre-Bonet, 2008; Costa-Font and Garcia, 2003). 
However, if there is a way to inject further resources into the NHS (e.g. earmarked tax on 
health), the latter can be prevented.  
In any event, the introduction of restrictions to patient mobility will inevitably entail 
a redefinition of the traditional values of ‘free access at the point of use’ which are largely 
supported by 89 per cent of the British public11, 
 and  may operate as ‘small events’ to introduce  restrictions to health care 
entitlements.  In addition, charges for emergency care can have knock-on effects on the 
health of asylum seekers and refugees entering Britain. Nonetheless, whether the status 
quo prevails or not will depend on the power and influence of key health system 
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stakeholders (e.g. medical profession, trade unions etc) and, particularly, their capacity to 
confront pressures for an increased role for the private sector. That is, whether or not they 
are able to tilt the balance of the quality–cost conundrum back into relaxing fiscal pressures 
so as to  maintain the traditional quality standards.    Given that Brexit reduces the existing 
constraints on employment quality (if the WTD is not implemented) alongside ‘equality and 
patient choice’ (if EU legislation is not implemented), it is unlikely to render further 
improvements in efficiency and equity.   
 
Nonetheless, Brexit brings some opportunities too, including the possibility of 
redefining the NHS in new directions. It might prevent or reduce a hypothetical future ‘race 
to the bottom’ ( a reduction in health entitlements from cross-country health system 
competition) in health care services if it ever developed. However, so far evidence of such a 
race to the bottom has not been substantiated (Costa-Font et al., 2014). Furthermore, given 
that health care is a devolved responsibility in the UK, it is likely that it will exhibit different 
effects in different countries of the UK, and especially in Scotland and Northern Ireland if 
they remain part of the UK. This might exacerbate the existing diversity between the 
different models of health care devolution in the UK (Greer, 2010). Hence, as hypothesized 
in this paper's title, Brexit, or a version of it, will mean hectic times for the NHS.  
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Notes 
 
                                                     
1
 This compares to other estimates on the effects of foregoing EU membership which range between 8.6 to 
10.6 per cent (Crafts, 2016) 
2
 The UK will not benefit from the 2018 harmonization process taking place within the EU which implies losing 
out on some important clinical trials that might otherwise benefit patients as the country would no longer be 
part of the harmonized procedure (King’s Fund, 2016). There are some other restrictions to mention, namely, 
the UK and the EU would be required to maintain separate databases on pharmaceutical products in the 
market, and the move of the European Medicines Agency (EMA) out of London will erode some proximity 
advantages. The UK will not enjoy access to a single application to licence and authorise a new product. This 
will result in higher costs.  
 
3
 The Observer newspaper (March 18) quoted a paradigmatic example of a Spanish nurse stating: ‘Since Brexit, 
I feel like a second-class citizen. My son asked me if I was going to be forced back to Spain and my daughter 
24 
 
                                                                                                                                                                     
doesn’t want to visit her grandparents because she fears I will not be able to come back’. See: 
https://www.theguardian.com/society/2017/mar/18/nhs-eu-nurses-quit-record-numbers 
 
4
 Under the OMC, the Council of Ministers decides upon a common set of goals and each Member State then 
develops a national action plan which includes guidelines, timetables and indicators. 
5
 That is, country-specific economic recommendations and fiscal adjustment programs (Azzopardi-Muscat et al, 
2015). 
6
 For instance, some argue that without the EU, it is unlikely that UK advocates would have resisted the 
pressure of tobacco industry lobbies in banning tobacco advertising (McKee and Glasworthy, 2016). 
7
 Similarly, Baker (2016) finds important differences in the presence of EU health care staff across the country, 
and specifically, finds a higher concentration in London (15 per cent of all staff).   
8
 This is an important point considering that the UK had to introduce several exemptions affecting nurses and 
midwives Tier 2 immigration salary thresholds. 
9
 In other words, prior authorisation was an essential constituent of cross-border patient mobility.  Regulation 
1408/71 in the early 1970s (later supplanted by Regulation 574/72) held that if a right to cross-border care 
exists, it is the responsibility of the appropriate institution in the competent state to pay for it, and if 
permission to receive treatment abroad is granted, this must be through the issue of an E112 form (in practice, 
member states would be reluctant to allow this if the necessary treatment could be provided at home). 
10
 To date, there are about 1.2 million British migrants living in other EU countries, compared with around 3 
million EU migrants living in the UK (Hawkins 2016). 
11
 Indeed, the majority of the British population (89 per cent) agrees that the government should support a 
national health system that is tax funded (British Social Attitude survey, 2014). 
